Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome
RecruitingOBSERVATIONAL
Enrollment
90
Participants
Timeline
Start Date
March 1, 2024
Primary Completion Date
December 1, 2025
Study Completion Date
May 1, 2026
Conditions
Ischemic Stroke
Trial Locations (1)
623702
RECRUITING
Brain Institute Clinic, Yekaterinburg
All Listed Sponsors
lead
POLYSAN Scientific & Technological Pharmaceutical Company